Magnetic targeting of drug-conjugated iron oxide nanoparticles has the potential to increase the concentration of therapeutic agents to tumours whilst reducing off-target side effects of current chemotherapy methods. This preclinical work demonstrates that SPION accumulation can be increased in subcutaneous tumours using magnetic fields and can then be detected by MRI. In addition, key physiological parameters can be measured before magnetic targeting for future optimisation of the strategy.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords